Chart: Revenue Breakdown for Structure Therapeutics. Values in USD billions. In Q2 2026: Revenue 0, Gross Profit 0, Operating Income -0.119.
Revenue Flow
Chart: Revenue Flow for Structure Therapeutics. Q2 2026, values in USD. Revenue 0, Cost of Revenue 0, Gross Profit 0, Net Income -0.106, Operating Income -0.119.
Balance Sheet
Chart: Balance Sheet for Structure Therapeutics. Values in currency. In Q2 2026: Total Assets 1.425, Total Liabilities 0.071, Total Equity 1.354.
Q3 2022-Q2 2026(All available data)
Cash Flow
Chart: Cash Flow for Structure Therapeutics. Values in currency. In Q2 2026: Operating Cash Flow -0.12, Free Cash Flow -0.12, Capital Expenditures 0.